10/12/2026
Hana Schwierling, a pharmaceutical sciences doctoral student at the University of Cincinnati James L. Winkle College of Pharmacy, has been recognized for her innovative research on traumatic brain injury (TBI).
Hana's research focuses on how traumatic brain injuries affect serotonin neurons and how those changes may contribute to long-term neurological and mental health challenges. By studying these mechanisms, researchers hope to develop more effective treatments for patients living with the effects of TBI.
Her work was recognized as a Top 20 Poster at the 2026 Annual Symposium of the National Neurotrauma Society, and she also received a travel award to present her research at a national pharmacology conference.
Read more here: https://www.uc.edu/news/articles/2026/09/uc-pharmaceutical-sciences-doctoral-student-brain-research.html
Congratulations Hana!